Triple-negative breast cancer (TNBC) is a definition encompassing all breast cancers with no/low immunohistochemically detectable expression of estrogen receptor α and progesterone receptor, and a lack of genomic amplification of ERBB2/HER2 [25,26]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.